<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Blood and Cancer</title>
<title_fa></title_fa>
<short_title>Iranian Journal of Blood and Cancer</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijbc.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-4595</journal_id_issn>
<journal_id_issn_online>2008-4609</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/ijbc</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>2008-4595</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1398</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2019</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<volume>11</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Immunophenotyping of Nodal Peripheral T-cell Lymphomas and its Association with Epstein-Barr Virus</title>
	<subject_fa>Pathology</subject_fa>
	<subject>Pathology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>Background: Immunophenotyping in the rare group of nodal Peripheral T-cell Lymphomas (PTCL) exposes interesting features such as T-cell marker downregulation and paradoxically, the presence of reactive, clustered large-sized CD20 positive B-cells (B-cell proliferation). Epstein-Barr virus (EBV) has been suggested as a putative etiology in pathogenesis of B-cell lymphoma. We aimed to review the immunohistochemical profile of patients with nodal PTCL with emphasis on T-cell markers and immunophenotypic aberrations, CD20 positive large B-cells, Ki-67 scores (as a measure of proliferation index) and to assess the association of Epstein-Barr virus in various subtypes of nodal PTCL.&lt;br&gt;
Methods: 80 cases of nodal PTCL diagnosed during January 2008-June 2013 were included in the study. Relevant clinical and hematological data were collected. Using Streptavidin-Biotin-Peroxidase system, staining for CD2, CD3, CD4, CD5, CD7, CD8, CD20,EBV-LMP1 and Ki-67 were performed on all blocks.CD10,CD23,Bcl-6, CD30 and ALK-1 were used in relevant cases.&lt;br&gt;
Results: 95% of patients had downregulation of at least one T-cell marker (maximum: CD7 (87%), minimum: CD3 and CD5- 9% each). 29 patients (36%) showed markers of B-cell proliferation. Only five patients (6%) were positive for EBV-LMP1. There was a significant association between EBV-LMP1 positivity and B-cell proliferation (P=0.002). 17 patients (21%) had high Ki-67 index (&amp;ge;80%).&lt;br&gt;
Conclusion: Nodal PTCL showed frequent downregulation of T-cell markers. EBV was only infrequently positive in these Lymphomas. Clusters of large B-cells need to be noted in pathology reports and EBV needs to be tested for in such cases.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Peripheral T-cell lymphoma, Immunophenotyping, Epstein-Barr virus, Angioimmunoblastic T-cell lymphoma, Anaplastic large cell lymphoma, Anaplastic lymphoma kinase</keyword>
	<start_page>101</start_page>
	<end_page>108</end_page>
	<web_url>http://ijbc.ir/browse.php?a_code=A-10-445-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Bidish Kumar </first_name>
	<middle_name></middle_name>
	<last_name>Patel</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>nappingbee@gmail.com</email>
	<code>10031947532846004957</code>
	<orcid>10031947532846004957</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Post Doctoral Fellow in Department of Cytogenetics</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Debdatta </first_name>
	<middle_name></middle_name>
	<last_name>Basu</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>ddbasu@gmail.com</email>
	<code>10031947532846004958</code>
	<orcid>10031947532846004958</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Senior Professor of Pathology</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Rakhee </first_name>
	<middle_name></middle_name>
	<last_name>Kar</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>drrakheekar@gmail.com</email>
	<code>10031947532846004959</code>
	<orcid>10031947532846004959</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Additional Professor of Pathology</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Biswajit </first_name>
	<middle_name></middle_name>
	<last_name>Dubashi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>drbiswajitdm@gmail.com</email>
	<code>10031947532846004960</code>
	<orcid>10031947532846004960</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Additional Professor of Medical Oncology</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
